Aytu BioPharma Inc (AYTU)

NASD · Healthcare · Drug Manufacturers - Specialty & Generic · USA

Aytu BioPharma Inc is a micro cap company (market value under $300 million) in the Drug Manufacturers - Specialty & Generic industry.

Aytu BioPharma manufactures and sells prescription pharmaceuticals addressing central nervous system conditions. Its current portfolio includes EXXUA for major depressive disorder, as well as Adzenys and Cotempla for attention deficit hyperactivity disorder, along with Karbinal for allergic conditions. The company distributes these medications through third-party wholesalers and pharmacies in the United States.

From its FY2026 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Aytu BioPharma Inc stock.

Our verdict on AYTU

Not valued: We cannot value this company yet.

We do not publish a value for this company: not even its current assets cover what it owes.

ETFs with the most weight in AYTU

3 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Drug Manufacturers - Specialty & Generic

All 82 Drug Manufacturers - Specialty & Generic stocks

Cheaper than AYTU in Drug Manufacturers - Specialty & Generic

33 more in this industry show a wider margin of safety.

Is AYTU undervalued or overvalued?

We do not publish a verdict on AYTU yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of AYTU?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.